Good morning everyone, welcome to Ambea's First Quarter 2021 Report Presentation. Speaking is Mark Jensen, CEO of Ambea, presenting with me today is Benno Eliasson, CFO. I will start today's presentation by giving an overview of the quarter and the status around COVID-19 and its effects on our business. I will also cover the status of our growth drivers. Benno will then describe the development of the financials for the groups and go through the financial development for the different segments in Ambea. I will then summarize the quarter and compare to our financial targets before we open up for questions. Before we start, a quick overview of the Ambea group. Ambea is the leading care provider in Scandinavia, with focus on residential care in a number of segments. We have a leading position in all our geographies with total revenues of around SEK 11 billion. Let's start with highlighting some important events from the quarter. COVID-19 continues to negatively affect the quarter, even though the situation in our operations has stabilized as the vaccination program rolled out. The negative effect from COVID-19 in the first quarter was in line with our estimates in the quarter four 2020 report at SEK 40 million on EBITDA. As occupancy has yet to show material improvements, the estimated effect on sales came in at SEK 100 million in the first quarter. Sales was down 3% compared to quarter one last year, driven by lower occupancy in Vardaga and currency effects in Stendi and Altiden. Termination of contracts also pressured sales growth. Adjusted EBITDA was down 19% versus last year and came in at SEK 152 million. Margin decreased to 5.5% from 6.7% versus same quarter last year. COVID-19 pressured earnings as occupancy was lower than during the same quarter last year. Stendi saw increased costs due to the pandemic as the Norwegian society experienced an increased spread of the coronavirus. During the quarter, Nytida closed the acquisition of six care units from LSS Omsorgen. After the quarter ended, Egefondens care operations in Denmark was acquired by Altiden. More on that later. First, let's look at an update on the COVID-19 situation. We can conclude that the spread of the virus has been substantially lower in our nursing homes than in the Swedish society during the first quarter. The situation in our nursing homes has stabilized, and operations return to an almost normal state again. We continue to be careful and ensure that previously implemented routines are in place to ensure our caretakers and their relatives can feel secure in our nursing homes. The vaccination program is completed in our nursing homes, with all residents and a majority of staff given the second dose of vaccine. Even though the stability has returned to our units, the financial impact remains due to a lower occupancy. Both Vardaga and Stendi had increased negative financial effects in the quarter. As Norway experienced the highest level of COVID-19 spread today, our cost for keeping residents and employees safe increased. The negative EBITDA effect from COVID-19 is SEK -40 million in quarter one and is predominantly shown in Vardaga and Stendi. Occupancy continued to be lower than normal, but at the same time, we cautiously focused to lower operating costs to mitigate the loss in revenues. Looking ahead, we estimate the negative impact of COVID-19 on the second quarter to SEK 90 million-SEK 100 million on sales and SEK 40 million-SEK 50 million on EBITDA, primarily due to lower occupancy. Moving on to the next slide where we compare the development of nursing home residents in Sweden. We have summarized publicly available data on the number of residents living in nursing homes from January 2020 until February 2021, which is the latest public data available. If we compare the development of Sweden and the Stockholm region to the development of the mature and own managed units in Vardaga, there are a number of interesting conclusions that can be drawn. The COVID-19 pandemic initially hit harder in the Stockholm region than in the rest of Sweden. A vast majority of our own managed mature units are in the Stockholm region. While the occupancy followed the same trend as Stockholm. Since the completion of the vaccination program within elderly care, the situation has stabilized, and the everyday life returned to normal in our nursing homes, including opportunities to receive visits from relatives and the daily activities for residents. In parallel, we carefully keep our implemented routines in place. The market generally works in the way that municipalities aim to fill vacancies in their own nursing homes first, then nursing homes on contract management, and as a third step, nursing homes in the private sector, where the municipalities pay per resident on a fully variable model. Over the last two months, we have seen a slight positive trend in occupancy for our own managed mature nursing homes, as seen in the graph. It is uncertain how the trend will continue to develop, our weekly data from April shows a continued slight positive trend. Short term, we have intensified our marketing and sales efforts to fill up the vacant capacity. Midterm, we will open additional capacity as we see the demand continue to increase. Long term, the demographic trend continue to be favorable. Turning to our profitability development where the EBITDA margin was 7.7% on a rolling 12-month basis. As previously noted, the profitability is negatively affected by COVID-19. Vardaga's margin decreased due to a continued low occupancy and added cost for newly opened units. We keep initiating new measures and operational improvements to optimize costs as we see a positive occupancy trend. Nytida shows a lower margin in the first quarter due to a decreased occupancy in the individual and family segment and a shift towards more contract management. All in all, the total rolling 12 month EBITDA margin decreased by 0.2 percentage points compared to the fourth quarter in 2020. Moving on to the greenfield development. We continue to experience a challenging environment regarding opening of new nursing homes in Sweden. Many municipalities still have empty beds in their own nursing homes. Ambea takes a cautious approach, and we will only open up and staff new nursing homes if we feel comfortable that they have a high likelihood of filling up within a 12 to 18 months timeframe. If not, we initiate discussions with our real estate owners to delay construction or just keep them empty with no staff costs until the occupancy situation is back to normal again in the local market. We currently have five to 10 such situations. In Q1, we opened up two group accommodation units. Nytida opened one in Stockholm with five beds. Altiden opened one in Jutland with five beds. In quarter two, we plan to open three new nursing homes, two in Sweden and one in Denmark. Vardaga will open Villa Stallgången in Eskilstuna and Villa Näs in Österåker, situated north of Stockholm, with a total of 120 beds. Finally, we are very excited about the opening of Fribo Holte. Altiden's first own-management unit, late quarter two. Let's turn to acquisitions. Nytida closed the acquisition of six care units from LSS Omsorgen in the quarter. We're happy to see the units continue to perform well after the acquisition. After the quarter ended, Altiden closed the acquisition of Egefondens Care Operations in Denmark. Egefondens Care Operations offers residential accommodation within disabled care and has about SEK 330 million in annual sales. The Egefondens acquisition is in line with our strategy for the Danish market, where we focus to shift business mix to segments with better long-term profitability, meaning own management residential care for elderly and individuals with disabilities. Now, let's look at the financial development of the quarter. Benno, over to you. Thank you, Mark. If we look into how the different business areas have affected the group numbers, we can see on the next slide that total sales declined by 3% or SEK 74 million. Last year had one day more, which represents SEK 31 million in sales. Starting with Vardaga, sales were down SEK 50 million. Important to remember that most of the SEK 100 million that we report as corona impact was in Vardaga, where occupancy was lower than normal. In total, the decline in sales was -5% versus last year. Nytida sales increased by SEK 7 million or 1%, mainly related to new contracts started. Contract management grew by 19%, while own management declined by 2%. Sales in Nytida is only to a low extent affected by corona. In Stendi, currency effect continues to affect the reported SEK numbers. The average NOK/SEK rate is down 3% versus Q1 last year, which means that sales in local currency is -1% versus last year. That's down SEK 30 million reported in SEK. We have returned one nursing home to a municipality, which represents around 3% of sales. In Altiden, we have started to leave the home care business and have returned two contracts to the municipalities as well as one nursing home. We had a small growth of own management driven by higher occupancy. Currency effect was unfavorable by 4%. At last, Klara. We saw now reported good growth in both external and internal sales. The increased external sales affected the group numbers by SEK 6 million. To the profit numbers. As said, we are facing both negative calendar effects of around SEK 30 million as well as negative corona effects compared to the first quarter 2020. Vardaga decreased EBITDA by SEK 23 million or margin by 2.4 percentage points. Due to corona, we saw lower occupancy in mature units as well as longer ramp-up times in new units. The Nytida margin was hurt by a change in mix between own management and contract management, as well as slightly lower occupancy as said in the individual and family segment. In Stendi, the restructuring program completed earlier last year now had full effect, we saw more corona-related costs than in previous quarters. The hard quarantine rules in the third wave, in combination with lower cost coverage from the government, has negatively impacted the EBITDA in the quarter. Altiden had a good quarter with solid occupancy levels. We are starting then to close down the home care business and prepare for further planned strategic initiatives in the second quarter. Klara continues to deliver stable margins. All in all, a decrease from SEK 187 million- SEK 152 million, or margin down from 6.7%- 5.6%. Cash flow. The strong operating cash flow continued. The first quarter is normally the weakest quarter from a cash flow perspective. Q1 was slightly weaker than last year, SEK 276 million versus SEK 298 last year. The rolling 12 cash conversion is still above 100%. If we exclude the IFRS 16 effect, we are at the operating cash flow at SEK 45 million in the quarter or SEK 860 million at rolling 12, which also is above 100% of the EBITDA excluding IFRS 16. Financing. The leverage of the group was at 3.5x EBITDA, which is 0.5x lower than one year ago, but 0.4x higher than the last quarter. The seasonal lower cash flow together with lower EBITDA this quarter has of course affected the numbers in the quarter. If we look back and compare with the same quarter last year, we have decreased our net debt by almost SEK 500 million and come from a net debt ratio of 4.0%- 3.5% as said as of now. The increase in lease debts is of almost SEK 1.2 billion since last year, reflects the fact that we have had a number of startups of new units under own management, and these units, they come with longer rental conditions than the average portfolio. A short overview of the business areas, starting with Vardaga, where total sales reached SEK 859 million in the quarter. That was down 5% versus last year. This is mostly driven by lower occupancy in mature units, but also a decline in contract management due to ceased contracts. New units in ramp-up have affected the sales positively versus last year, but not as much as expected. We continue to see a slower ramp-up pace in these new units due to the COVID-19 situation. EBITDA for Vardaga reached SEK 25 million versus SEK 48 million last year. Most of the negative corona effect of the SEK 100 million in sales and SEK 40 million that we reported in the group hit Vardaga. We also saw overall operational improvement, which compensated for some of the lost occupancy. That indicates that the margin improvement can come rapidly when the occupancy rates are increasing again in our own management portfolio. The quarterly earnings was also positively affected by retroactive compensation for COVID-19 costs by SEK 20 million. The EBITDA margin for mature units decreased to 7.2% in Q1 from 9.8% last year. This decline was, of course, driven by the lower occupancy. The benefit from all experience drawn in the pandemic, we are in the final stages of our COVID-19 analysis of Vardaga. In our report, which will be presented in a few weeks from now, we will discuss and present potential improvements to strengthen and secure an individually adapted elderly care in Sweden. We also aim to accelerate our efforts to decrease the risk of society building a social care debt on the backside of the pandemic. Many relatives have taken a larger responsibility during the pandemic as their loved ones in need of care have stayed at home. It's now time to get the professional care needed, and as an important partner to the municipalities, Ambea can provide a secure and individually adapted high-quality care. Over to Nytida, where total sales reached SEK 990 million in the quarter, up 1% versus last year. Own management sales was slightly down, reaching SEK 764 million in the quarter. This was an effect of low occupancy in our units' focus on individual and family care. Our disabled care business, which is the core segment of Nytida, continues to be stable. Contract management sales reached SEK 155 million. That is up 19% versus last year. Strong win rates during 2020 have turned around the negative sales trend we have previously had in contract management. EBITDA reached SEK 114 million in the quarter, corresponding to a 12.4% margin. This is a decrease by 1.7 percentage points, and is mainly explained by shift towards more contract management and decreased occupancy in the individual and family segment. Rolling 12 EBITDA margin reached 15.9%. That is down 0.4 percentage points versus Q4 last year. Over to Norway and Stendi. Sales decreased 4% and reached SEK 731 million. Currency effect had a negative impact in the quarter. Sales in local currency decreased by 1% versus the same quarter last year. In local currency, the own management sales increased by 2%, but in SEK, sales decreased by 1% and reached SEK 674 million. Contract management sales reached SEK 57 million versus SEK 75 million last year. That decline is explained by return of a nursing home back in Q2 2020. Quarterly earnings was positively affected by the ongoing efforts to implement Ambea's care model in combination with synergies from the previously completed restructuring program. Costs for COVID-19-related sick leave, the strict quarantine rules, and cost for protective equipment continued to increase compared to previous quarter, which had a negative effect on EBITDA in the quarter. Adjusted EBITDA reached SEK 50 million, or a margin of 2.1% in the quarter versus 1.7% last year. That profit increase mostly comes from the cost improvement program that we launched in Q1 2020. Adjusted rolling 12 EBITDA margin increased by 0.1 percentage points from Q4 and are now at 4.7%. Over to Denmark and Altiden. Sales amounted to SEK 151 million, and that is down 11% versus last year, explained mainly by the return of low-margin contracts in elderly care. In local currency, the sales decreased by 7%. In the first quarter, Altiden had an EBITDA of SEK 1 million, and the EBITDA was positively affected by the higher occupancy compared to the same quarter last year. There is also COVID-19-related costs that negative affected profitability. At last, Klara. Net sales were up 17%, reaching SEK 89 million in the quarter, SEK 13 million up versus last year. The positive development versus last year is predominantly in the staffing business, where the demand for our nurses have increased. Klara continues to perform well with an EBITDA of SEK 6 million, in line with the same quarter last year. Rolling 12 EBITDA margin now reached 7.9% in the fourth quarter. On that note, back to you, Mark. Thank you so much, Benno. Time for concluding remarks. First, to sum up our financial development versus our targets. Our growth target is 8%-1 0% through a combination of acquired and organic growth. 2021 shows the negative effects from COVID-19, but we have announced two acquisitions in the first quarter of 2021. LSS Omsorgen in Sweden and Egefonden's care homes in Denmark. We continue to actively explore attractive M&A possibilities in all our markets and pursue new greenfield opportunities in relevant locations. Profitability-wise, we have a midterm adjusted EBITDA target of 9.5%. Q1 2021 was the first rolling 12-month period where we had full effects from the pandemic. We are well-positioned, we believe, to meet an increase in demand post the pandemic. Finally, regarding leverage, where cutoff effects in quarter one, as well as a lower profitability, resulted in a higher leverage, but our solid cash conversion will reduce leverage over time. Summarizing on a one-pager here, the first quarter of 2021. COVID-19 is still affecting operations and our financials, and we are still in a pandemic. We should not forget that. With vaccination programs progressing rapidly in society overall, and concluded within elderly care, we expect to see a slightly more positive occupancy trend in the coming quarters. The financials were negatively affected from COVID-19 by SEK 100 million on sales and SEK 40 million on EBITDA in the quarter. For the second quarter, we expect the negative impact of the pandemic to be SEK 90 million-SEK 100 million on sales and SEK 40 million-SEK 50 million on EBITDA. Our COVID-19 report regarding the elderly care segment in Sweden will be presented in the coming weeks. It aims to draw conclusions and suggest improvement measures. Make sure to visit our website to read it. We continue to be active in M&A and have completed two new acquisitions as per today, one in Nytida and one in Altiden. We believe Ambea is well positioned to capture the growth and demand we expect to see when our society slowly returns to normal. As a partner to the municipalities, we are ready to support and deliver quality solutions for residential care. With that, I conclude our presentation and open up for questions. Operator, can we have the first question, please? Thank you. The first question comes from line of Karl Norén from Danske Bank. Please ask your question. If we can start on the Nytida segment, and maybe if you could explain a bit more, what was the driver or the reason behind the lower demand that you saw within individual and family care? Do you see it as more of a one-off effect, or should we expect lower demand to remain for the upcoming few quarters? Thanks. We saw the lower demand in the individual and family segment, predominantly in the sub-segment of children and youth. We don't really know if that is a direct or indirect effect of the pandemic or not. We have seen that for a few quarters. We see it still in the first quarter. That hit the profitability a little bit more in the first quarter than previous. Okay. It's hard to say really if that is a continuing trend or that will be back to normal when we are a little bit out of the pandemic. Okay. The next question is here to try to figure out the underlying development on EBITDA. The SEK 20 million that you received in government support, can you say how much you have calculated of that to be in the Q2 when you calculate the impact, or when you estimate the impact to be SEK 40 million-SEK 50 million in Q2, just to figure out the underlying development there? The SEK 20 million we got in Vardaga was the last portion of the 2020 Government Program that we didn't know when we closed our books for 2020 if we should get or not. Now we know that we got it, and we booked it in the Q1. We have not anticipated yet any subsidies from the Swedish Government Program in Q2, and we are not really sure how the program would work in 2021. We know that the municipalities haven't yet got that kind of money that they got in 2020. We are a little bit cautious in our estimates there. If there will be some money, that would be, of course, affect the guidance that we just made. Karl. Okay. Just the last question here. Can you quantify maybe the negative impact from COVID in Stendi? How much was it in Q1, if you could estimate it? No, I don't have an exact number of that, but that is more than just a couple of millions, you can say. It's more than just marginal, that you can say. Thank you. Yeah. Thank you. Thank you. The next question comes to line of Kristofer Liljeberg from Carnegie. Please ask your question. Thank you. Just to follow up on the last one here, the split of the COVID-19 impact in Norway and Swedish elder care. If you could come back with a figure there, it would be very helpful to understand the underlying trend. Maybe particularly so in Norway, since much of the story is about improving margins long term in Norway. Besides that, could you say something more about what you see for occupancy rates and the trend in April? Do you see any type of acceleration, although from small levels, or is it as slow as we saw in March as well? You saw from the graph that we showed in the presentation that we have seen in February and March a slight positive trend. That trend continues, what we can see from our weekly data in April. It's not accelerating, but it's continued to be slightly positive. I think it's also important to notice here that the way it works, as I tried to explain on the slide, is that the municipalities will normally fill up their own nursing homes first, then go to contract management, and then to the private sector in the third step. We'll be positioned at step three, you could say, in the filling up the vacant capacity again. We see definitely the same positive trend from our weekly data in April. Is this the trend you see throughout Sweden, or is it more so in different geographies? As we have our own managed homes concentrate in the Stockholm region, it's predominantly from here we see it, and it's from municipalities where you have the opportunity to make a free choice of where you want to stay. This is areas where we see we have the strongest development. Okay. How soon do you think you will have occupancy levels in Sweden above last year? Also best guess now, when do you think occupancy levels could get back to pre-COVID levels? Do you think it will be difficult to get back to pre-COVID levels in the next coming years or so? We don't think it'll be difficult to come back long term. It's very hard to say how fast it will come back short term. I think we have all been a little surprised by this pandemic from time to time. First the second wave, and then the third wave in society overall. I don't mean now Ambea, but society overall and the impact of that. The impact of the third wave in Norway, I think to the Norwegian society was quite impactful. We cannot say which quarter we will be above last year, how fast we'll be back to pre-COVID levels. Long term, the underlying trend is still very strong, and we will get there, but we cannot say exactly when. Based on your sales guidance for the COVID impact on sales guidance for the second quarter, it seems you estimate only marginally better occupancy levels, correct? Yeah, that's correct. Yeah. Okay. Last question. Is it possible to get the IFRS 16 lease effect in the financial net? I see that you give it out on the EBITA line. To get the impact on net profit, that would be helpful as well. Well, I don't have that figure right now, but we'll see if we can add that later on in the future presentations. Okay. Thank you. Thank you, dear participants. If you wish to ask question, please press star and one on your telephone keypad. The next question comes from line of Pål-Johan Bonnevier from DNB Markets. Please ask your question. Yes, good morning. Just to continue on Vardaga, having five to 10 units, as you say, in not ready, but not in ramp up, so to say. Is that a very high cost burden for you in the short term, having it like that? You'd really would like to get into normalization, also ramping them up quickly? Or how much of the cost have you been able to mitigate? In these five to 10 units, we have the rent cost, of course, in our books, but we don't have any staff or other costs. Rent cost is normally maybe 20% of the total cost for having a full nursing home or something like that. Of course, it hurts our margin, but over time, we think we can bear that volume. I think it's more important that we fill up our existing homes and our ramp-up homes than if it's five or six of these units. Excellent. When you look at turning those units into ramp up, how quickly can it go if occupancy levels start to materially improve again? We have them ready. We say that staff up and start the business is around a three-month period of time or something like that. It's that quick. Rather quickly, yeah. Rather quickly if we see that the local market is coming back. Mark, if possible, it would be very interesting to hear your take on the landscape the company is now facing, looking at opportunity and risk, and maybe particularly talking about how you see the heightened political rhetoric about, say, private care service providers and what they contribute to the sector. I noticed your discussions about the care debt and operational improvements suggested and these kinds. Sounds like you're going after this a little more proactively. It's still early days for me. I'm only eight weeks in, but I think the sector has a very positive outlook overall. We know we have the demographic with us long term. We see definitely a need for high-quality professional care solutions in all our markets. What we have been kind of trying to convey here over the last few weeks is that it's important that the society does not build up a social care debt here on the backside of the pandemic, because we know that many relatives have been looking after their loved ones, staying at home now during the pandemic, and that has been for more than one year now. Many of these elderly people, or it could be also younger people with need of social care, should get professional care now. What we are stating is that it's now safe and secure to return. The vaccination program is concluded within elderly care. The overall vaccination program in society is rolling out now very fast in all Nordic markets. Simply the relatives should now, with, of course, our partners, the municipalities, think of what is the right next step for the loved ones that are in need of professional care. If we don't fix that, we will end up with a care debt longer term that will be expensive for society overall, and that would not be a good outcome of the pandemic, where we have other debts to deal with, so to say. I think this is an important point to highlight, because we see, in some areas, relative low activity in the municipalities because simply loved ones are being looked after by their relatives, and that has been now the situation for quite some time, and there is really no need for that anymore. Overall, I will say that the long-term outlook, I believe, is still very favorable. All data I have looked into shows that in our segments. We have well-positioned business units in all the Nordic markets. I think we have a solid plan also for the Danish market, the Norwegian market. We are of course impacted by the pandemic, and everyone had hoped that we would have been accelerating a little faster out of the pandemic than what we are. That's the situation we're in, and we will deal with it, and we will get out of it also in a good way. Excellent. Thank you for the extra color. Thank you. Dear participants, if you wish to ask a question, please press star and one on your telephone keypad. There are no further questions at this time. I would like to hand the conference over to the speaker for the closing remarks. Thank you so much. Thanks for today's call. No more questions. Thank you for calling in. The Quarter two report will be published on July 23rd. Have a nice day, everyone. Stay safe and healthy.